A novel artificial intelligence biomarker: Validation of the automated bone scan index (aBSI) in veterans with metastatic prostate cancer.

被引:0
|
作者
Durkal, Vipal P.
Nickols, Nicholas George
Rettig, Matthew
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17507
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Automated Bone Scan Index (aBSI) as an Imaging Biomarker in Castration Sensitive Prostate Cancer
    Alshehri, A.
    O'Sullivan, J.
    Prise, K.
    Jain, S.
    Turner, P.
    Campfield, C.
    Biggart, S.
    Chatzigiannis, C.
    Cole, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1115 - S1116
  • [2] Analytical Validation of Automated Bone Scan Index (BSI) as an Imaging Biomarker in Patients with Metastatic Prostate Cancer (mPC)
    Anand, Aseem
    Morris, Michael
    Minarik, David
    Bjartell, Anders
    Edenbrandt, Lars
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [3] Computer automated bone scan index (BSI) as an analytically validated imaging biomarker to quantitate change in bone scan of patients with metastatic prostate cancer.
    Anand, Aseem
    Minarik, David
    Kaboteh, Reza
    Belal, Sarah Lindgren
    Reza, Mariana
    Joseffson, Andreas
    Edenbrandt, Lars
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
    Anand, Aseem
    Morris, Michael J.
    Kaboteh, Reza
    Bath, Lena
    Sadik, May
    Gjertsson, Peter
    Lomsky, Milan
    Edenbrandt, Lars
    Minarik, David
    Bjartell, Anders
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (01) : 41 - 45
  • [5] Analytical Validation of Automated Bone Scan Index as a Candidate Imaging Biomarker for Advance Prostate Cancer
    Anand, A.
    Edenbrandt, L.
    Bjartell, A.
    Minarik, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S499 - S499
  • [6] Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC).
    Armstrong, Andrew J.
    Edenbrandt, Lars
    Bondesson, Eva
    Anand, Aseem
    Nordle, Orjan
    Carducci, Michael Anthony
    Morris, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Aseem Anand
    Michael J. Morris
    Steven M. Larson
    David Minarik
    Andreas Josefsson
    John T. Helgstrand
    Peter S. Oturai
    Lars Edenbrandt
    Martin Andreas Røder
    Anders Bjartell
    EJNMMI Research, 6
  • [8] Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Anand, Aseem
    Morris, Michael J.
    Larson, Steven M.
    Minarik, David
    Josefsson, Andreas
    Helgstrand, John T.
    Oturai, Peter S.
    Edenbrandt, Lars
    Roder, Martin Andreas
    Bjartell, Anders
    EJNMMI RESEARCH, 2016, 6
  • [9] Automated bone scan index as an imaging biomarker in metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223.
    Anand, Aseem
    Daignault, Stephanie
    Nordquist, Luke T.
    Ramos, Jorge
    Jain, Rohit K.
    McDonald, Matthew
    Campbell, Gregory
    George, Saby
    Albany, Costantine
    Yu, Evan Y.
    Bjartell, Anders
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC).
    Anand, Aseem
    Morris, Michael J.
    Larson, Steven M.
    Ohlsson, Mattias
    Joseffson, Andreas
    Helgstrand, John Thomas
    Edenbrandt, Lars
    Oturai, Peter Sander
    Roeder, M. Andreas
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)